Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Cancer Research|April 5, 2018
Adoptive Immunotherapy Using PRAME-Specific T Cells in MedulloblastomaDomenico Orlando, Evelina Miele, Biagio De Angelis, et al.
Molecular Oncology|September 13, 2020
Downregulation of miR-326 and its host gene β-arrestin1 induces pro-survival activity of E2F1 and promotes medulloblastoma growthEvelina Miele, Agnese Po, Angela Mastronuzzi, et al.
The EMBO Journal|December 6, 2014
Gli1/DNA interaction is a druggable target for Hedgehog-dependent tumorsPaola Infante, Mattia Mori, Romina Alfonsi, et al.
Ecotoxicology and Environmental Safety|January 21, 2026
Chronic low-dose cadmium exposure accelerates the onset and metastasis of invasive mammary carcinoma and promotes immunosuppression in the tumor microenvironment in BALB-neuT miceChiara Focaccetti, Daniela Nardozi, Monica Benvenuto, et al.
Oncogenesis|November 6, 2019
KCTD15 inhibits the Hedgehog pathway in Medulloblastoma cells by increasing protein levels of the oncosuppressor KCASH2Eleonora Spiombi, Annapaola Angrisani, Simone Fonte, et al.
Diabetologia|March 19, 2025
Comprehensive sequencing profile and functional analysis of IsomiRs in human pancreatic islets and beta cellsStefano Auddino, Elena Aiello, Giuseppina E Grieco, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 18, 2023
A diagnostic circulating miRNA signature as orchestrator of cell invasion via TKS4/TKS5/EFHD2 modulation in human gliomasAna Belén Díaz Méndez, Andrea Sacconi, Elisa Tremante, et al.
Biomarker Research|June 17, 2022
MiR-1248: a new prognostic biomarker able to identify supratentorial hemispheric pediatric low-grade gliomas patients associated with progressionGiuseppina Catanzaro, Zein Mersini Besharat, Andrea Carai, et al.
Nature Communications|March 9, 2018
Itch/β-arrestin2-dependent non-proteolytic ubiquitylation of SuFu controls Hedgehog signalling and medulloblastoma tumorigenesisPaola Infante, Roberta Faedda, Flavia Bernardi, et al.
International Journal of Cancer|December 15, 2020
Upfront treatment with mTOR inhibitor everolimus in pediatric low-grade gliomas: A single-center experienceAntonella Cacchione, Mariachiara Lodi, Andrea Carai, et al.
Pageof 7